Date of submission of the HTAC Recommendation: 20 July 2026Date of notification to HTAC on the SOH decision: 26 August 2026 The Secretary of Health (SOH) concurs with the final recommendation of the HTA Council on levothyroxine sodium 12.5 micrograms (mcg) and 25 mcg tablets for the management of hypothyroidism of any etiology through Department continue reading : HTA Council Final Recommendation on levothyroxine sodium 12.5 micrograms (mcg) and 25 mcg tablets for the management of hypothyroidism of any etiology
HTA Council Final Recommendation on norepinephrine (as tartrate) 1mg/mL concentrate solution for IV infusion in 8mL ampule for cardiogenic or vascular shock that persists after adequate fluid volume replacement; severe hypotension; and, (as first-choice vasopressor) treatment of sepsis and septic shock in adults
Date of submission of the HTAC Recommendation: 20 July 2026Date of notification to HTAC on the SOH decision: 26 August 2026 The Secretary of Health (SOH) concurs with the final recommendation of the HTA Council on norepinephrine (as tartrate) 1mg/mL concentrate solution for IV infusion in 8mL ampule for cardiogenic or vascular shock that persists continue reading : HTA Council Final Recommendation on norepinephrine (as tartrate) 1mg/mL concentrate solution for IV infusion in 8mL ampule for cardiogenic or vascular shock that persists after adequate fluid volume replacement; severe hypotension; and, (as first-choice vasopressor) treatment of sepsis and septic shock in adults
HTA Council Final Recommendation on Multiple Micronutrient Supplement (MMS) film-coated tablet for the prevention of vitamin and mineral deficiencies, improvement of iron status, and reduction of anemia among pregnant and lactating women (with Secretary of Health Decision)
Date of submission of the HTAC Recommendation: 13 February 2026Date of notification to HTAC on the SOH decision: 02 June 2026 The Secretary of Health (SOH) concurs with the final recommendation of the HTA Council on multiple micronutrient supplement (MMS) film-coated tablet for the prevention of vitamin and mineral deficiencies, improvement of iron status, and continue reading : HTA Council Final Recommendation on Multiple Micronutrient Supplement (MMS) film-coated tablet for the prevention of vitamin and mineral deficiencies, improvement of iron status, and reduction of anemia among pregnant and lactating women (with Secretary of Health Decision)
HTA Council Final Recommendation on gadobutrol (1) 1.0 mmol/mL solution for intravenous (IV) injection, 7.5 mL, in a clear colorless glass vial and (2) 1.0 mmol/mL solution for IV injection, 7.5 mL in a type 1 colorless glass pre-filled syringe (PFS) for use in diagnostic magnetic resonance imaging (MRI) in adults and children (with Secretary of Health Decision)
Date of submission of the HTAC Recommendation: 11 June 2026Date of notification to HTAC on the SOH decision: 20 July 2026 The Secretary of Health (SOH) concurs with the final recommendation of the HTA Council on gadobutrol (1) 1.0 mmol/mL solution for intravenous (IV) injection, 7.5 mL, in a clear colorless glass vial and (2) 1.0 continue reading : HTA Council Final Recommendation on gadobutrol (1) 1.0 mmol/mL solution for intravenous (IV) injection, 7.5 mL, in a clear colorless glass vial and (2) 1.0 mmol/mL solution for IV injection, 7.5 mL in a type 1 colorless glass pre-filled syringe (PFS) for use in diagnostic magnetic resonance imaging (MRI) in adults and children (with Secretary of Health Decision)